Silicon Laboratories Inc. — Form 10-K Summary
Period clarification: The supplied filing is the annual report for the fiscal year ended December 29, 2012 (52 weeks), not a 2011 Q4 filing. It also reports fiscal 2012 Q4 results and compares them with fiscal 2011.
Business context and reporting period
Silicon Laboratories designs analog-intensive, mixed-signal integrated circuits for communications, consumer, industrial, automotive and other applications. It operates as a fabless semiconductor company, relying principally on TSMC and other third parties for manufacturing, assembly and testing. The company reports one operating segment.
In July 2012, Silicon Labs acquired Ember Corporation, adding low-power wireless ICs and mesh-networking software. Samsung represented 19% of fiscal 2012 revenue, up from 13% in fiscal 2011; the ten largest end customers accounted for 43%. Edom Technology and Avnet represented 22% and 11% of revenue, respectively. 88% of revenue was shipped outside the United States.
Financial performance and liquidity
| Metric | Fiscal 2012 | Fiscal 2011 |
|---|---|---|
| Revenue | $563.3 million | $491.6 million |
| Gross profit / margin | $338.0 million / 60.0% | $298.4 million / 60.7% |
| Operating income / margin | $85.7 million / 15.2% | $50.1 million / 10.2% |
| Net income / margin | $63.5 million / 11.3% | $35.5 million / 7.2% |
| Diluted EPS | $1.47 | $0.79 |
| Cash from operations | $97.1 million | $88.7 million |
- Revenue increased 14.6%; unit volume rose 18.0%, while average selling prices fell 3.0%. Management attributed growth mainly to market-share gains and Ember revenue.
- Annual gross margin declined 0.7 percentage points, primarily due to product mix and acquisition-related charges. Higher revenue and lower operating expenses as a share of sales helped lift operating and net margins.
- Fiscal 2012 Q4 revenue was $152.5 million versus $126.7 million in Q4 2011; operating income was $25.3 million versus $15.2 million, and net income was $18.7 million versus $12.8 million. Q4 diluted EPS was $0.44 versus $0.29.
- At year-end, cash, cash equivalents and investments totaled $293.4 million, including $282.0 million in cash, cash equivalents and short-term investments; working capital was $361.3 million. Cash and short-term investments included $119.4 million held by U.S. entities.
- Accounts receivable rose to $78.0 million from $55.4 million; inventory increased to $49.6 million from $34.8 million. DSO rose to 46 days from 39, and inventory days to 76 from 63.
- Investing activities used $139.3 million, reflecting higher property-and-equipment spending and business acquisitions. Financing activities provided $52.7 million, including $98.3 million net debt proceeds, partly offset by $62.0 million of share repurchases.
Debt, material changes and unusual items
- The company borrowed $100 million under a five-year term loan in September 2012. It also had a $130 million revolving credit facility, undrawn at year-end. The loan balance was $100 million; the company reported covenant compliance. A swap fixed the LIBOR component through July 2017; the reported combined rate was 2.514% at year-end.
- Fiscal 2012 investing outflows included the Ember acquisition, purchased for approximately $79.0 million including estimated contingent consideration, and the purchase of Austin headquarters facilities for $94.4 million. The headquarters transaction produced an $8.5 million gain recorded in SG&A.
- SG&A included approximately $3.2 million of expense under the former CEO’s separation agreement, including severance and accelerated/modified equity awards. The company also recorded $0.7 million of intangible-asset impairment in SG&A.
- The effective tax rate was 26.4%, down from 32.2%, principally reflecting the release of prior-year unrecognized tax benefits. A law enacted in January 2013 retroactively reinstated the federal R&D tax credit; management estimated a $3.5–$4.0 million fiscal 2012 tax benefit for recognition in Q1 2013.
- The company repurchased $62.0 million of stock in fiscal 2012. In January 2013, the board authorized a new repurchase program of up to $50 million through January 2014. No cash dividends were paid or expected in the foreseeable future.
Outlook, risks and contingencies
- Management expected Q1 fiscal 2013 revenue to decline sequentially by 4%–8% and diluted EPS of $0.34–$0.40. It expected modestly higher R&D expense and relatively stable SG&A in Q1; fiscal 2013 capital expenditures were estimated at $14–$18 million.
- Management said existing cash, investments and credit availability were expected to fund working capital, capital expenditures, investments and commitments for at least 12 months.
- Key risks include customer and distributor concentration, cancellable purchase orders, pricing pressure and product obsolescence, inventory exposure from forecasts, lengthy design-win and qualification cycles, and reliance on third-party manufacturing and testing—particularly TSMC and suppliers concentrated in Asia.
- Other risks include intense competition, dependence on successful new products and acquisitions, intellectual-property disputes, international and geopolitical disruptions, and potential yield, quality or supply-capacity problems. The company cited $12.5 million par value of auction-rate securities with failed auctions and limited liquidity; fair value was $11.4 million.
- Silicon Labs and MaxLinear were involved in multiple patent disputes, including infringement allegations and counterclaims. The company said the outcome and financial effect could not be predicted. Other ordinary-course legal matters were not expected to materially affect the financial statements.
- The financial statements received an unqualified audit opinion, and management and the auditor reported effective internal control over financial reporting as of year-end.
Most important facts for investors to verify
- Whether Q1 2013 revenue and EPS guidance was achieved, and whether growth and margins persisted after the strong Q4.
- How much of fiscal 2012 revenue growth came from Ember and market-share gains, and whether lower average selling prices continue to pressure gross margin.
- Whether receivables and inventory growth, including higher DSO and inventory days, translated into collections or inventory write-down risk.
- Debt repayment, covenant headroom, use of the undrawn revolver, and the cash available after acquisitions, capital spending and repurchases.
- Ember product milestones and contingent consideration, the MaxLinear litigation outcome, and the recoverability/liquidity of auction-rate securities.